$1.24
-0.06-4.62%
OS Therapies Inc (OSTX) Stock Price, Quote, News & History
OSTXAMEX
OS Therapies reports a 72.7% three-year survival rate in its Phase 2b osteosarcoma trial, preparing for global regulatory submissions.
You can purchase shares of OS Therapies (AMEX:OSTX) through any online brokerage.
Other companies in OS Therapies’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
OS Therapies has a consensus price target of $15.20.
The stock price for OS Therapies (AMEX: OSTX) is $ last updated .
There are no upcoming dividends for OS Therapies.
OS Therapies does not have any upcoming earnings scheduled.
There is no upcoming split for OS Therapies.
OS Therapies is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The company's mission is to address the need for new...
